Literature DB >> 15269455

Immune response to Toxoplasma gondii.

Denis Filisetti1, Ermanno Candolfi.   

Abstract

Oral-route infection with Toxoplasma gondii sporozoites or tachyzoites leads to the rapid spread of quick-replicating cytolytic tachyzoites throughout the whole body. Toxoplasma easily crosses the blood-retina, encephalic and placental barriers. The acute phase of this infection lasts for less than around ten days. The parasite causes a very strong type-1 response focused on the interferon-gamma secreted by the T lymphocytes. This immune response limits the tissue extension of the parasite, ensuring the survival of the host, but, paradoxically, also aiding the survival of the parasite by converting it into a bradyzoite, an intracellular quiescent resistant form persisting in the muscle and brain tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269455

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  44 in total

1.  Serological study of Toxoplasma gondii infection in Turkoman horses in the North Khorasan Province, Iran.

Authors:  G R Razmi; V Abedi; S Yaghfoori
Journal:  J Parasit Dis       Date:  2014-08-31

2.  Women infected with parasite Toxoplasma have more sons.

Authors:  S Kanková; J Sulc; K Nouzová; K Fajfrlík; D Frynta; J Flegr
Journal:  Naturwissenschaften       Date:  2006-09-30

3.  Cellular immune response and scanning electron microscopy in the evaluation of Moringa leaves aqueous extract effect on Cryptosporidium parvum in buffalo intestinal tissue explants.

Authors:  Dina Aboelsoued; Nagwa I Toaleb; Kadria N Abdel Megeed; Soad E Hassan; Sally Ibrahim
Journal:  J Parasit Dis       Date:  2019-03-18

4.  Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level.

Authors:  Mona Ibrahim Ali; Wegdan Mohamed Abd El Wahab; Doaa Ahmed Hamdy; Ahmed Hassan
Journal:  J Parasit Dis       Date:  2019-03-30

5.  Indoleamine 2,3-dioxygenase is involved in defense against Neospora caninum in human and bovine cells.

Authors:  Katrin Spekker; Markus Czesla; Vanessa Ince; Kathrin Heseler; Silvia K Schmidt; Gereon Schares; Walter Däubener
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

6.  The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.

Authors:  Mona M El Temsahy; Eman D H El Kerdany; Maha M Eissa; Thanaa I Shalaby; Iman M Talaat; Nermine M F H Mogahed
Journal:  J Parasit Dis       Date:  2014-09-05

7.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

8.  Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.

Authors:  Marcin M Grzybowski; Bożena Dziadek; Justyna M Gatkowska; Katarzyna Dzitko; Henryka Długońska
Journal:  Parasitol Res       Date:  2015-09-04       Impact factor: 2.289

9.  BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1.

Authors:  B F Barbosa; D A O Silva; I N Costa; J R Mineo; E A V Ferro
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

10.  Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.

Authors:  Young-Ha Lee; Dae-Whan Shin; Jae-Ho Lee; Ho-Woo Nam; Myoung-Hee Ahn
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.